389 articles in this topic
![Environmental Toxin Benzo[a]pyrene Linked to Ovarian Cancer Through Gut Microbiome](/_next/image?url=https%3A%2F%2Fd18eact5vmeulb.cloudfront.net%2Fthumbnails%2Fenvironmental-toxin-benzoapyrene-linked-to-ovarian-cancer-through-gut-microbiome.jpg%3Fv%3D1775197834184&w=3840&q=75)
Multi-omics study reveals how the carcinogen benzo[a]pyrene may trigger ovarian cancer via gut bacteria and molecular pathways.
Comprehensive genetic analysis of early-stage lung adenocarcinoma identifies molecular subtypes that predict patient outcomes better than current methods.
Sequential CDK4/6 inhibitor treatment before anti-PD-1 therapy enhances immune response and tumor control in head and neck cancer models.
Flaxseed compounds enhance PD-1 inhibitor effectiveness against breast cancer through gut bacteria modulation and immune system activation.
New technique uses cerebrospinal fluid to decode methylation signatures in children's brain tumors, potentially improving diagnosis.
New research reveals how selenium deficiency drives liver cancer progression through neutrophil aging and immune suppression.
New research reveals how cancer radiation treatment causes muscle weakness through a previously unknown tumor-muscle communication pathway.
New research reveals how hepatoma cells evade immunotherapy by secreting N1-acetylspermidine to suppress immune function.
Combining two targeted drugs plus dietary changes shows superior cancer-fighting potential in lab studies of breast and endometrial cancers.
Research identifies genetic and environmental factors that may help predict who develops pancreatic neuroendocrine tumors and their outcomes.
New ColonTrack model identifies early-stage colorectal cancer with 94% accuracy using three proteins from blood-based extracellular vesicles.
New research reveals cancer cells can escape therapy-induced senescence, creating a reversible drug resistance mechanism that may contribute to tumor relapse.
